whitepaper-banner

Biocatalytic Innovation in Asymmetric Synthesis: Enzyme-Promoted Transamination for Drug APIs

At AcceleDev, biocatalysis isn’t just a trend. It’s a powerful, proven tool for achieving cleaner, more efficient, and scalable synthesis. This white paper focuses on enzyme-promoted transamination to create high-purity chiral amines and intermediates, sharing real-world case studies that demonstrate its advantages in yield, waste reduction, and sustainability. A practical, experience-driven guide for pharma teams evaluating when and how to use biocatalysis to move their programs forward.


AcceleDev is committed to your privacy. Your information will be used solely to deliver this white paper and occasional updates about custom synthesis, process chemistry, or CDMO insights. You can unsubscribe at any time.

AcceleDev